Next Article in Journal
Salvia miltiorrhiza and Its Compounds as Complementary Therapy for Dyslipidemia: A Meta-Analysis of Clinical Efficacy and In Silico Mechanistic Insights
Next Article in Special Issue
The Efficacy of Fluvoxamine in Anxiety Disorders and Obsessive-Compulsive Disorder: An Overview of Systematic Reviews and Meta-Analyses
Previous Article in Journal
Advice to the FDA to Improve Its Proposed Guidelines to Rationalize Clinical Trials by Restricting Placebo Control, Preventing Low-Powered Studies, and Disallowing Studies Where Bioavailability Is Not Proven
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(11), 1425; https://doi.org/10.3390/ph17111425
Action Date Notes Link
article xml file uploaded 24 October 2024 13:30 CEST Original file -
article xml uploaded. 24 October 2024 13:30 CEST Update https://www.mdpi.com/1424-8247/17/11/1425/xml
article pdf uploaded. 24 October 2024 13:30 CEST Version of Record https://www.mdpi.com/1424-8247/17/11/1425/pdf
article supplementary file uploaded. 24 October 2024 13:30 CEST - https://www.mdpi.com/1424-8247/17/11/1425#supplementary
article html file updated 24 October 2024 13:31 CEST Original file https://www.mdpi.com/1424-8247/17/11/1425/html
Back to TopTop